相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Self-Assembly of DNA-Grafted Colloids: A Review of Challenges
Manish Dwivedi et al.
MICROMACHINES (2022)
Micropatterned Neurovascular Interface to Mimic the Blood-Brain Barrier's Neurophysiology and Micromechanical Function: A BBB-on-CHIP Model
Ajay Vikram Singh et al.
CELLS (2022)
Perspectives on the Technological Aspects and Biomedical Applications of Virus-Like Particles/Nanoparticles in Reproductive Biology: Insights on the Medicinal and Toxicological Outlook
Vaisali Chandrasekar et al.
ADVANCED NANOBIOMED RESEARCH (2022)
Emerging Application of Nanorobotics and Artificial Intelligence To Cross the BBB: Advances in Design, Controlled Maneuvering, and Targeting of the Barriers
Ajay Vikram Singh et al.
ACS CHEMICAL NEUROSCIENCE (2021)
Design of liposomes as drug delivery system for therapeutic applications
Diana Guimaraes et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2021)
Combination of targeted daunorubicin liposomes and targeted emodin liposomes for treatment of invasive breast cancer
Min Fu et al.
JOURNAL OF DRUG TARGETING (2020)
Co-delivery of epirubicin and paclitaxel using an estrone-targeted PEGylated liposomal nanoparticle for breast cancer
Huan Tang et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Catalase-based liposomal for reversing immunosuppressive tumor microenvironment and enhanced cancer chemo-photodynamic therapy
Chao Shi et al.
BIOMATERIALS (2020)
Coencapsulation of disulfiram and doxorubicin in liposomes strongly reverses multidrug resistance in breast cancer cells
Francesca Rolle et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2020)
Development of a novel liposomal nanoparticle formulation of cisplatin to breast cancer therapy
Mehrnaz Ghafari et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2020)
Anticancer Effect of Metformin in Herceptin-Conjugated Liposome for Breast Cancer
Ji-Yeon Lee et al.
PHARMACEUTICS (2020)
Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer
Jing Wang et al.
CARBOHYDRATE POLYMERS (2020)
Overexpression of Extradomain-B Fibronectin is Associated with Invasion of Breast Cancer Cells
Amita Vaidya et al.
CELLS (2020)
Engineering peptide -targeted liposomal nanoparticles optimized for improved selectivity for HER2-positive breast cancer cells to achieve enhanced in vivo efficacy
Baksun Kim et al.
JOURNAL OF CONTROLLED RELEASE (2020)
Co-delivery of a RanGTP inhibitory peptide and doxorubicin using dual-loaded liposomal carriers to combat chemotherapeutic resistance in breast cancer cells
Yusuf Haggag et al.
EXPERT OPINION ON DRUG DELIVERY (2020)
Co-delivery of resveratrol and p53 gene via peptide cationic liposomal nanocarrier for the synergistic treatment of cervical cancer and breast cancer cells
Xiaodong Xu et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2019)
Liposomal co-delivery-based quantitative evaluation of chemosensitivity enhancement in breast cancer stem cells by knockdown of GRP78/CLU
Annie Agnes Suganya Samson et al.
JOURNAL OF LIPOSOME RESEARCH (2019)
Temperature-sensitive liposomes for co-delivery of tamoxifen and imatinib for synergistic breast cancer treatment
Anup Jose et al.
JOURNAL OF LIPOSOME RESEARCH (2019)
Cationic liposome codelivering PI3K pathway regulator improves the response of BRCA1-deficient breast cancer cells to PARP1 inhibition
Haipeng Zhang et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2019)
Cell Permeable NBD Peptide-Modified Liposomes by Hyaluronic Acid Coating for the Synergistic Targeted Therapy of Metastatic Inflammatory Breast Cancer
Yuqing Sun et al.
MOLECULAR PHARMACEUTICS (2019)
Ultrasonically controlled albumin-conjugated liposomes for breast cancer therapy
Nahid S. Awad et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2019)
Dual complementary liposomes inhibit triple-negative breast tumor progression and metastasis
Peng Guo et al.
SCIENCE ADVANCES (2019)
Liposomes modified with double-branched biotin: A novel and effective way to promote breast cancer targeting
Runxin Lu et al.
BIOORGANIC & MEDICINAL CHEMISTRY (2019)
Co-Delivery of Paclitaxel and PLK1-Targeted siRNA Using Aptamer-Functionalized Cationic Liposome for Synergistic Anti-Breast Cancer Effects In Vivo
Sheng Yu et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2019)
Short and Long-Term Effects of the Exposure of Breast Cancer Cell Lines to Different Ratios of Free or Co-Encapsulated Liposomal Paclitaxel and Doxorubicin
Marina Santiago Franco et al.
PHARMACEUTICS (2019)
Vitamin E D-alpha-tocopheryl polyethylene glycol 1000 succinate-conjugated liposomal docetaxel reverses multidrug resistance in breast cancer cells
Na Li et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2019)
A nuclear targeted Dox-aptamer loaded liposome delivery platform for the circumvention of drug resistance in breast cancer
Xin Li et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
Folate-coated, long-circulating and pH-sensitive liposomes enhance doxorubicin antitumor effect in a breast cancer animal model
Juliana de Oliveira Silva et al.
BIOMEDICINE & PHARMACOTHERAPY (2019)
EGFR-targeted immunoliposomes as a selective delivery system of simvastatin, with potential use in treatment of triple-negative breast cancers
Lucyna Matusewicz et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Metformin-Encapsulated Liposome Delivery System: An Effective Treatment Approach against Breast Cancer
Snehal K. Shukla et al.
PHARMACEUTICS (2019)
Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy
Ying Yang et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
Folate receptor-targeted liposomal nanocomplex for effective synergistic photothermal-chemotherapy of breast cancer in vivo
Van Du Nguyen et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2019)
In the triple-negative breast cancer MDA-MB-231 cell line, sulforaphane enhances the intracellular accumulation and anticancer action of doxorubicin encapsulated in liposomes
Lidia Mielczarek et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2019)
Dual-targeting liposomes with active recognition of GLUT5 and αvβ3 for triple-negative breast cancer
Yanchi Pu et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2019)
Synergetic estrogen receptor-targeting liposome nanocarriers with anti-phagocytic properties for enhanced tumor theranostics
Yuehua Wang et al.
JOURNAL OF MATERIALS CHEMISTRY B (2019)
Anti-MUC1/CD44 Dual-Aptamer-Conjugated Liposomes for Cotargeting Breast Cancer Cells and Cancer Stem Cells
Dong-Min Kim et al.
ACS APPLIED BIO MATERIALS (2019)
Tumor homing peptide modified liposomes of capecitabine for improved apoptotic activity and HER2 targeted therapy in breast cancer: in vitro studies
Mantosh Kumar Singh et al.
RSC ADVANCES (2019)
Co-encapsulation of thymoquinone with docetaxel enhances the encapsulation efficiency into PEGylated liposomes and the chemosensitivity of MCF7 breast cancer cells to docetaxel
Fadwa Odeh et al.
HELIYON (2019)
Selective induction of apoptosis in MCF7 cancer-cell by targeted liposomes functionalised with mannose-6-phosphate
Cristina Minnelli et al.
JOURNAL OF DRUG TARGETING (2018)
Antitumor activity of nanoliposomes encapsulating the novobiocin analog 6BrCaQ in a triple-negative breast cancer model in mice
Felix Sauvage et al.
CANCER LETTERS (2018)
Surface modification of paclitaxel-loaded liposomes using d-alpha-tocopheryl polyethylene glycol 1000 succinate: Enhanced cellular uptake and cytotoxicity in multidrug resistant breast cancer cells
Su-Min Han et al.
CHEMISTRY AND PHYSICS OF LIPIDS (2018)
Development of liposomal pemetrexed for enhanced therapy against multidrug resistance mediated by ABCC5 in breast cancer
Fang Bai et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Docetaxel-trastuzumab stealth immunoliposome: development and in vitro proof of concept studies in breast cancer
Anne Rodallec et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2018)
Folate-targeted liposomal nitrooxy-doxorubicin: An effective tool against P-glycoprotein-positive and folate receptor-positive tumors
Elena Gazzano et al.
JOURNAL OF CONTROLLED RELEASE (2018)
Specific delivery of idarubicin to HER2-positive breast cancerous cell line by trastuzumab-conjugated liposomes
Mansour Amin et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2018)
Hyaluronic acid modified daunorubicin plus honokiol cationic liposomes for the treatment of breast cancer along with the elimination vasculogenic mimicry channels
Rui-Jun Ju et al.
JOURNAL OF DRUG TARGETING (2018)
Liposomal Codelivery of Doxorubicin and Andrographolide Inhibits Breast Cancer Growth and Metastasis
Xuejia Kang et al.
MOLECULAR PHARMACEUTICS (2018)
Anticancer Efficacy of Targeted Shikonin Liposomes Modified with RGD in Breast Cancer Cells
Xianchun Wen et al.
MOLECULES (2018)
Tumour Heterogeneity of Breast Cancer: From Morphology to Personalised Medicine
Mohammed A. Aleskandarany et al.
PATHOBIOLOGY (2018)
Dual Receptor Targeting Cell Penetrating Peptide Modified Liposome for Glioma and Breast Cancer Postoperative Recurrence Therapy
Yue Qiu et al.
PHARMACEUTICAL RESEARCH (2018)
Ultrasonically controlled estrone-modified liposomes for estrogen-positive breast cancer therapy
Najla M. Salkho et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Octreotide-modified liposomes containing daunorubicin and dihydroartemisinin for treatment of invasive breast cancer
Rui-Jun Ju et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2018)
Cationic liposomes for co-delivery of paclitaxel and anti-Plk1 siRNA to achieve enhanced efficacy in breast cancer
Upendra Bulbake et al.
JOURNAL OF DRUG DELIVERY SCIENCE AND TECHNOLOGY (2018)
被撤回的出版物: Breast Cancer Chemo-immunotherapy through Liposomal Delivery of an Immunogenic Cell Death Stimulus Plus Interference in the IDO-1 Pathway (Retracted article. See vol. 15, pg. 10735, 2021)
Jianqin Lu et al.
ACS NANO (2018)
Breast cancer development and progression: Risk factors, cancer stem cells, signaling pathways, genomics, and molecular pathogenesis
Yixiao Feng et al.
GENES & DISEASES (2018)
Novel CD44-downstream signaling pathways mediating breast tumor invasion
Allal Ouhtit et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES (2018)
'Nano-in-nano' hybrid liposomes increase target specificity and gene silencing efficiency in breast cancer induced SCID mice
Dhiraj Bhavsar et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Anti-HER2 immunoliposomes for co-delivery of paclitaxel and rapamycin for breast cancer therapy
Josimar O. Eloy et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2017)
Liposomal curcumin alters chemosensitivity of breast cancer cells to Adriamycin via regulating microRNA expression
Siying Zhou et al.
GENE (2017)
The use of functional epirubicin liposomes to induce programmed death in refractory breast cancer
Lei Liu et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Targeted multidrug delivery system to overcome chemoresistance in breast cancer
Yuan Tang et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2017)
Targeted co-delivery of polypyrrole and rapamycin by trastuzumab-conjugated liposomes for combined chemo-photothermal therapy
Hanh Thuy Nguyen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Co-delivery of paclitaxel and anti-survivin siRNA via redox-sensitive oligopeptide liposomes for the synergistic treatment of breast cancer and metastasis
Xinyan Chen et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2017)
Pegylated liposomal formulation of doxorubicin overcomes drug resistance in a genetically engineered mouse model of breast cancer
Andras Fueredia et al.
JOURNAL OF CONTROLLED RELEASE (2017)
Cell death mechanistic study of photodynamic therapy against breast cancer cells utilizing liposomal delivery of 5,10,15,20-tetrakis(benzo[b]thiophene) porphyrin
Geewoo Nam et al.
JOURNAL OF PHOTOCHEMISTRY AND PHOTOBIOLOGY B-BIOLOGY (2017)
Construction and evaluation of pH-sensitive immunoliposomes for enhanced delivery of anticancer drug to ErbB2 over-expressing breast cancer cells
Tianshu Li et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Tyroservatide-TPGS-paclitaxel liposomes: Tyroservatide as a targeting ligand for improving breast cancer treatment
Xin Jin et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2017)
Enhanced cytotoxicity by a benzothiazole-containing cisplatin derivative in breast cancer cells
Chaoqun You et al.
NEW JOURNAL OF CHEMISTRY (2017)
Liposomal Nanoparticles Carrying anti-IL6R Antibody to the Tumour Microenvironment Inhibit Metastasis in Two Molecular Subtypes of Breast Cancer Mouse Models
Chunlei Guo et al.
THERANOSTICS (2017)
Tumor Heterogeneity in Breast Cancer
Gulisa Turashvili et al.
FRONTIERS IN MEDICINE (2017)
Combination of using prodrug-modified cationic liposome nanocomplexes and a potentiating strategy via targeted co-delivery of gemcitabine and docetaxel for CD44-overexpressed triple negative breast cancer therapy
Yang Fan et al.
ACTA BIOMATERIALIA (2017)
Somatostatin receptor targeted liposomes with Diacerein inhibit IL-6 for breast cancer therapy
Rashmi Bharti et al.
CANCER LETTERS (2017)
Surface-modified Epirubicin-HCl liposomes and its in vitro assessment in breast cancer cell-line: MCF-7
Ravi Gandhi et al.
DRUG DELIVERY (2016)
Curcumin-guided nanotherapy: a lipid-based nanomedicine for targeted drug delivery in breast cancer therapy
Mingzhen Lin et al.
DRUG DELIVERY (2016)
Improved therapeutic activity of HER2 Affibody-targeted cisplatin liposomes in HER2-expressing breast tumor models
Seyedeh Hoda Alavizadeh et al.
EXPERT OPINION ON DRUG DELIVERY (2016)
PEGylated liposomes of anastrozole for long-term treatment of breast cancer: in vitro and in vivo evaluation
Gopal Venkatesh Shavi et al.
JOURNAL OF LIPOSOME RESEARCH (2016)
RGD-Targeted Liposome Binding and Uptake on Breast Cancer Cells Is Dependent on Elastin Linker Secondary Structure
Eleftheria Veneti et al.
BIOCONJUGATE CHEMISTRY (2016)
Improvement in the drug delivery and anti-tumor efficacy of PEGylated liposomal doxorubicin by targeting RNA aptamers in mice bearing breast tumor model
Seyedeh Alia Moosavian et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Co-loaded paclitaxel/rapamycin liposomes: Development, characterization and in vitro and in vivo evaluation for breast cancer therapy
Josimar O. Eloy et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Hyaluronan-conjugated liposomes encapsulating gemcitabine for breast cancer stem cells
Na-Kyung Han et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2016)
Hyaluronic acid-coated liposomes for targeted delivery of paclitaxel, in-vitro characterization and in-vivo evaluation
Fatemeh Ravar et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Roles of nucleolin Focus on cancer and anti-cancer therapy
Zhuo Chen et al.
SAUDI MEDICAL JOURNAL (2016)
Efficacy of pegylated liposomal etoposide nanoparticles on breast cancer cell lines
Mohammadreza Mehrabi et al.
TURKISH JOURNAL OF MEDICAL SCIENCES (2016)
Micromixer Based Preparation of Functionalized Liposomes and Targeting Drug Delivery
Xiangqian Jia et al.
ACS MEDICINAL CHEMISTRY LETTERS (2016)
ICAM-1-Targeted, Lcn2 siRNA-Encapsulating Liposomes are Potent Anti-angiogenic Agents for Triple Negative Breast Cancer
Peng Guo et al.
THERANOSTICS (2016)
Therapeutic efficacy of doxorubicin delivery by a CO2 generating liposomal platform in breast carcinoma
Hee Dong Han et al.
ACTA BIOMATERIALIA (2015)
The roles of nucleolin subcellular localization in cancer
Caroline Madeleine Berger et al.
BIOCHIMIE (2015)
Reversal of multidrug resistance by co-delivery of paclitaxel and lonidamine using a TPGS and hyaluronic acid dual-functionalized liposome for cancer treatment
Assogba G. Assanhou et al.
BIOMATERIALS (2015)
Anti-cancer activity of pegylated liposomal trans-anethole on breast cancer cell lines MCF-7 and T47D
Shahedeh Shahbazian et al.
BIOTECHNOLOGY LETTERS (2015)
Experimental design of a liposomal lipid system: A potential strategy for paclitaxel-based breast cancer treatment
Marcos V. Barbosa et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Paclitaxel/Epigallocatechin gallate coloaded liposome: A synergistic delivery to control the invasiveness of MDA-MB-231 breast cancer cells
Satiesh Kumar Ramadass et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2015)
Dual targeting for metastatic breast cancer and tumor neovasculature by EphA2-mediated nanocarriers
Zhaoming Guo et al.
INTERNATIONAL JOURNAL OF PHARMACEUTICS (2015)
A Combination of Targeted Sunitinib Liposomes and Targeted Vinorelbine Liposomes for Treating Invasive Breast Cancer
Ji-Feng Shi et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Targeting Epirubicin Plus Quinacrine Liposomes Modified with DSPE-PEG(2000)-C(RGDfK) Conjugate for Eliminating Invasive Breast Cancer
Meng-Ge Sun et al.
JOURNAL OF BIOMEDICAL NANOTECHNOLOGY (2015)
Estrogen receptors in breast carcinogenesis and endocrine therapy
Bo Huang et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2015)
Co-Eradication of Breast Cancer Cells and Cancer Stem Cells by Cross-Linked Multi lamellar Liposomes Enhances Tumor Treatment
Yu Jeong Kim et al.
MOLECULAR PHARMACEUTICS (2015)
Targeted delivery of doxorubicin to breast cancer cells by aptamer functionalized DOTAP/DOPE liposomes
Xingli Song et al.
ONCOLOGY REPORTS (2015)
CD44 as a potential diagnostic tumor marker
Nawwaf S. Basakran
SAUDI MEDICAL JOURNAL (2015)
Application of functional vincristine plus dasatinib liposomes to deletion of vasculogenic mimicry channels in triple-negative breast cancer
Fan Zeng et al.
ONCOTARGET (2015)
A7RC peptide modified paclitaxel liposomes dually target breast cancer
Jingyan Cao et al.
BIOMATERIALS SCIENCE (2015)
Functionalizing Liposomes with anti-CD44 Aptamer for Selective Targeting of Cancer Cells
Walhan Alshaer et al.
BIOCONJUGATE CHEMISTRY (2015)
17β-estradiol-containing liposomes as a novel delivery system for the antisense therapy of ER-positive breast cancer: An in vitro study on the MCF-7 cell line
Zbynek Heger et al.
ONCOLOGY REPORTS (2015)
Thioaptamer Conjugated Liposomes for Tumor Vasculature Targeting
Aman P. Mann et al.
Oncotarget (2015)
Targeted and controlled drug delivery using a temperature and ultra-violet responsive liposome with excellent breast cancer suppressing ability
Hua-Fei Li et al.
RSC ADVANCES (2015)
HER2 in Breast Cancer: A Review and Update
Uma Krishnamurti et al.
ADVANCES IN ANATOMIC PATHOLOGY (2014)
Liposomes, modified with PTDHIV-1 peptide, containing epirubicin and celecoxib, to target vasculogenic mimicry channels in invasive breast cancer
Rui-Jun Ju et al.
BIOMATERIALS (2014)
Combined mTOR inhibitor rapamycin and doxorubicin-loaded cyclic octapeptide modified liposomes for targeting integrin α3 in triple-negative breast cancer
Wenbing Dai et al.
BIOMATERIALS (2014)
Hydrophobic penetrating peptide PFVYLI-modified stealth liposomes for doxorubicin delivery in breast cancer therapy
Defu Cai et al.
BIOMATERIALS (2014)
Tamoxifen guided liposomes for targeting encapsulated anticancer agent to estrogen receptor positive breast cancer cells: In vitro and in vivo evaluation
Ankitkumar S. Jain et al.
BIOMEDICINE & PHARMACOTHERAPY (2014)
Expression and prognostic significance of fibronectin and matrix metalloproteases in breast cancer metastasis
Belen Fernandez-Garcia et al.
HISTOPATHOLOGY (2014)
The co-delivery of a low-dose P-glycoprotein inhibitor with doxorubicin sterically stabilized liposomes against breast cancer with low P-glycoprotein expression
Wei Gao et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2014)
Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands
Hirota Fujiki et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2014)
Inhibition of Metastatic Tumor Growth and Metastasis via Targeting Metastatic Breast Cancer by Chlorotoxin-Modified Liposomes
Chao Qin et al.
MOLECULAR PHARMACEUTICS (2014)
Tamoxifen embedded in lipid bilayer improves the oncotarget of liposomal daunorubicin in vivo
M. H. Li et al.
JOURNAL OF MATERIALS CHEMISTRY B (2014)
Modulation of drug-resistant membrane and apoptosis proteins of breast cancer stem cells by targeting berberine liposomes
Xu Ma et al.
BIOMATERIALS (2013)
Immunoliposome encapsulation increases cytotoxic activity and selectivity of curcumin and resveratrol against HER2 overexpressing human breast cancer cells
Angela Catania et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Trastuzumab-conjugated vitamin E TPGS liposomes for sustained and targeted delivery of docetaxel
Anandhkumar Raju et al.
EXPERT OPINION ON DRUG DELIVERY (2013)
Tumor-targeted liposomal drug delivery mediated by a diseleno bond-stabilized cyclic peptide
Chong Li et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2013)
Targeting combinations of liposomal drugs to both tumor vasculature cells and tumor cells for the treatment of HER2-positive breast cancer
Jennifer I. Hare et al.
JOURNAL OF DRUG TARGETING (2013)
Folate-modified-chitosan-coated liposomes for tumor-targeted drug delivery
Kui Kun Yang et al.
JOURNAL OF MATERIALS SCIENCE (2013)
Impact of Tumor HER2/ERBB2 Expression Level on HER2-Targeted Liposomal Doxorubicin-Mediated Drug Delivery: Multiple Low-Affinity Interactions Lead to a Threshold Effect
Bart S. Hendriks et al.
MOLECULAR CANCER THERAPEUTICS (2013)
Influence of tumour micro-environment heterogeneity on therapeutic response
Melissa R. Junttila et al.
NATURE (2013)
Selective delivery of an anticancer drug with aptamer-functionalized liposomes to breast cancer cells in vitro and in vivo
Hang Xing et al.
JOURNAL OF MATERIALS CHEMISTRY B (2013)
Drug Delivery of Hydroxyurea to Breast Cancer Using Liposomes
Seyed Ebrahim Alavi et al.
INDIAN JOURNAL OF CLINICAL BIOCHEMISTRY (2013)
Estrogen receptors and human disease: an update
Katherine A. Burns et al.
ARCHIVES OF TOXICOLOGY (2012)
Using breast cancer cell CXCR4 surface expression to predict liposome binding and cytotoxicity
Peng Guo et al.
BIOMATERIALS (2012)
The use of a tumor metastasis targeting peptide to deliver doxorubicin-containing liposomes to highly metastatic cancer
Zhaohui Wang et al.
BIOMATERIALS (2012)
Mitochondrial targeting liposomes incorporating daunorubicin and quinacrine for treatment of relapsed breast cancer arising from cancer stem cells
Liang Zhang et al.
BIOMATERIALS (2012)
Mitochondrial targeting topotecan-loaded liposomes for treating drug-resistant breast cancer and inhibiting invasive metastases of melanoma
Yang Yu et al.
BIOMATERIALS (2012)
Theranostic liposomes of TPGS coating for targeted co-delivery of docetaxel and quantum dots
Madaswamy S. Muthu et al.
BIOMATERIALS (2012)
Targeted and intracellular triggered delivery of therapeutics to cancer cells and the tumor microenvironment: impact on the treatment of breast cancer
Vera Moura et al.
BREAST CANCER RESEARCH AND TREATMENT (2012)
Development of anti-HB-EGF immunoliposomes for the treatment of breast cancer
Kaoru Nishikawa et al.
JOURNAL OF CONTROLLED RELEASE (2012)
Doxorubicin and chloroquine coencapsulated liposomes: preparation and improved cytotoxicity on human breast cancer cells
Liyan Qiu et al.
JOURNAL OF LIPOSOME RESEARCH (2012)
PEGylated Liposomal Doxorubicin Targeted to α5β1-Expressing MDA-MB-231 Breast Cancer Cells
Kamlesh Shroff et al.
LANGMUIR (2012)
Estrogen-Anchored pH-Sensitive Liposomes as Nanomodule Designed for Site-Specific Delivery of Doxorubicin in Breast Cancer Therapy
Shivani R. Paliwal et al.
MOLECULAR PHARMACEUTICS (2012)
Targeting Her-2+ Breast Cancer Cells with Bleomycin Immunoliposomes Linked to LLO
Max Kullberg et al.
MOLECULAR PHARMACEUTICS (2012)
In vitro mechanistic study of cell death and in vivo performance evaluation of RGD grafted PEGylated docetaxel liposomes in breast cancer
Sachin Naik et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
HER2-targeted liposomal doxorubicin displays enhanced anti-tumorigenic effects without associated cardiotoxicity
Joseph G. Reynolds et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
The promotion of siRNA delivery to breast cancer overexpressing epidermal growth factor receptor through anti-EGFR antibody conjugation by immunoliposomes
Jie Gao et al.
BIOMATERIALS (2011)
Differences in integrin expression and signaling within human breast cancer cells
Aliakbar Taherian et al.
BMC CANCER (2011)
Integrin α3β1 as a breast cancer target
Sita Subbaram et al.
EXPERT OPINION ON THERAPEUTIC TARGETS (2011)
Heterogeneity in breast cancer
Kornelia Polyak
JOURNAL OF CLINICAL INVESTIGATION (2011)
Efficient tumor regression by a single and low dose treatment with a novel and enhanced formulation of thermosensitive liposomal doxorubicin
Tatsuaki Tagami et al.
JOURNAL OF CONTROLLED RELEASE (2011)
All-trans retinoic acid stealth liposomes prevent the relapse of breast cancer arising from the cancer stem cells
Ruo-Jing Li et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Chondroitin sulfate functionalized liposomes for solid tumor targeting
Rashmi Bagari et al.
JOURNAL OF DRUG TARGETING (2011)
Targeting Therapy with Mitosomal Daunorubicin plus Amlodipine Has the Potential To Circumvent Intrinsic Resistant Breast Cancer
Yan Zhang et al.
MOLECULAR PHARMACEUTICS (2011)
Liposome formulation of co-encapsulated vincristine and quercetin enhanced antitumor activity in a trastuzumab-insensitive breast tumor xenograft model
Man-Yi Wong et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Liposomes Containing (-)-Gossypol-Enriched Cottonseed Oil Suppress Bcl-2 and Bcl-xL Expression in Breast Cancer Cells
Hong Li et al.
PHARMACEUTICAL RESEARCH (2011)
Liposomes as multicompartmental carriers for multidrug delivery in anticancer chemotherapy
Donato Cosco et al.
DRUG DELIVERY AND TRANSLATIONAL RESEARCH (2011)
A Review on Composite Liposomal Technologies for Specialized Drug Delivery
Maluta S. Mufamadi et al.
JOURNAL OF DRUG DELIVERY (2011)
Selectively targeting estrogen receptors for cancer treatment
Erin K. Shanle et al.
ADVANCED DRUG DELIVERY REVIEWS (2010)
Histological, molecular and functional subtypes of breast cancers
Gautam K. Malhotra et al.
CANCER BIOLOGY & THERAPY (2010)
Targeted drug delivery via folate receptors
Xiaobin Zhao et al.
EXPERT OPINION ON DRUG DELIVERY (2008)
Her2 cross talk and therapeutic resistance in breast cancer
Laura M. Bender et al.
FRONTIERS IN BIOSCIENCE (2008)
Folate receptor overexpression is associated with poor outcome in breast cancer
Lynn C. Hartmann et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
CD44 attenuates metastatic invasion during breast cancer progression
JI Lopez et al.
CANCER RESEARCH (2005)
分享论文
